tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

GB:AZN Stock Latest News

AstraZeneca overhauling management at China division, FT reports
The FlyAstraZeneca overhauling management at China division, FT reports
10h ago
AZN
AstraZeneca’s Datroway Gains US Approval for Advanced Breast Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s Datroway Gains US Approval for Advanced Breast Cancer Treatment
2d ago
AstraZeneca’s Datroway approved in U.S. for HER2-negative breast cancer patients
PremiumThe Fly
AstraZeneca’s Datroway approved in U.S. for HER2-negative breast cancer patients
4d ago
AZN
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
PremiumThe Fly
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
4d ago
AZN
BHC
AstraZeneca’s Calquence Wins FDA Approval for Mantle Cell Lymphoma
PremiumMarket News
AstraZeneca’s Calquence Wins FDA Approval for Mantle Cell Lymphoma
4d ago
AstraZeneca price target raised to 13,100 GBp from 12,600 GBp at Guggenheim
PremiumThe FlyAstraZeneca price target raised to 13,100 GBp from 12,600 GBp at Guggenheim
5d ago
AZN
AstraZeneca’s Calquence combination approved in U.S.
Premium
The Fly
AstraZeneca’s Calquence combination approved in U.S.
5d ago
AZN
AstraZeneca’s Calquence Gains FDA Approval for First-Line Mantle Cell Lymphoma Treatment
Premium
Company Announcements
AstraZeneca’s Calquence Gains FDA Approval for First-Line Mantle Cell Lymphoma Treatment
5d ago
Drugmakers to push Trump to pause price negotiations, Bloomberg reports
PremiumThe Fly
Drugmakers to push Trump to pause price negotiations, Bloomberg reports
7d ago
AZN
BMY
Ionis unveils pipeline plan for 2025, expects 4 independent product launches
PremiumThe Fly
Ionis unveils pipeline plan for 2025, expects 4 independent product launches
8d ago
AZN
IONS
Compugen initiated with an Outperform at Oppenheimer
PremiumThe Fly
Compugen initiated with an Outperform at Oppenheimer
8d ago
AZN
CGEN
AstraZeneca, Daiichi Sankyo datopotamab deruxtecan BLA granted priority review
PremiumThe Fly
AstraZeneca, Daiichi Sankyo datopotamab deruxtecan BLA granted priority review
9d ago
AZN
AstraZeneca call volume above normal and directionally bullish
PremiumThe FlyAstraZeneca call volume above normal and directionally bullish
15d ago
AZN
AstraZeneca call volume above normal and directionally bullish
Premium
The Fly
AstraZeneca call volume above normal and directionally bullish
19d ago
AZN
AstraZeneca Announces Share Capital and Voting Rights Update
Premium
Company Announcements
AstraZeneca Announces Share Capital and Voting Rights Update
19d ago
Hutchmed announces NDA acceptance in China, payment from AstraZeneca
PremiumThe Fly
Hutchmed announces NDA acceptance in China, payment from AstraZeneca
20d ago
AZN
HCM
Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders
PremiumClass Action
Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders
26d ago
AZN
Achilles Therapeutics sells technology assets to AstraZeneca for $12M
PremiumThe Fly
Achilles Therapeutics sells technology assets to AstraZeneca for $12M
28d ago
AZN
ACHL
AstraZeneca, Daiichi Sankyo have voluntarily withdrawn a Dato-DXd MAA in EU
PremiumThe Fly
AstraZeneca, Daiichi Sankyo have voluntarily withdrawn a Dato-DXd MAA in EU
29d ago
AZN
AstraZeneca Withdraws EU Application for Lung Cancer Drug
PremiumCompany AnnouncementsAstraZeneca Withdraws EU Application for Lung Cancer Drug
29d ago
AstraZeneca’s Tagrisso approved in EU for certain types of NSCLC
Premium
The Fly
AstraZeneca’s Tagrisso approved in EU for certain types of NSCLC
30d ago
AZN
AstraZeneca’s Tagrisso Gains EU Approval for Unresectable EGFR-Mutated Lung Cancer
Premium
Company Announcements
AstraZeneca’s Tagrisso Gains EU Approval for Unresectable EGFR-Mutated Lung Cancer
30d ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >